Skip to main content

clinical trials

By Jessica Hagen | 11:39 am | January 12, 2023
The U.K.-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.
By Jessica Hagen | 02:29 pm | January 03, 2023
The AI-enabled data company will integrate ATCOR and CONNEQT's technology into its platform in early 2023 to monitor maternal health and cardiovascular diseases.
By Emily Olsen | 02:27 pm | December 07, 2022
The company said it will use the capital to hire for its commercial teams and advance development on new features.
By Jessica Hagen | 07:47 pm | September 20, 2022
The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.
By Emily Olsen | 11:33 am | May 26, 2022
The London-based company most recently raised £5 million in Series A funding in 2020.
HIMSS22
By Emily Olsen | 03:01 pm | February 16, 2022
In a preview of her HIMSS22 session, Abbott's Jennifer Jones-McMeans explains how clinical studies can be structured to ensure a diverse population of participants.
HIMSS21
By HIMSS TV | 01:35 am | October 19, 2021
The long view for digital health as it relates to clinical trials is implementing innovative tools and processes that make sense for the patient, says Dr. Joy Bhosai, cofounder and CEO of Pluto Health.
By Tammy Lovell | 06:39 am | October 18, 2021
The market is forecast to reach $9.13 billion (€7.84 billion) by 2026.
By Laura Lovett | 04:23 pm | September 10, 2021
Panelists said better data collection and decentralized clinical trials may be one way to boost diversity efforts. 
HIMSS21
By HIMSS TV | 08:05 am | September 07, 2021
Chris Boone, global head of health economics and outcomes research at AbbVie, shares why pharmaceutical companies are still working to improve diversity in clinical trials.